位置:首页 > 蛋白库 > FLOT2_HUMAN
FLOT2_HUMAN
ID   FLOT2_HUMAN             Reviewed;         428 AA.
AC   Q14254;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   28-JUL-2009, sequence version 2.
DT   03-AUG-2022, entry version 183.
DE   RecName: Full=Flotillin-2;
DE   AltName: Full=Epidermal surface antigen;
DE            Short=ESA;
DE   AltName: Full=Membrane component chromosome 17 surface marker 1;
GN   Name=FLOT2; Synonyms=ESA1, M17S1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 8-428.
RC   TISSUE=Keratinocyte;
RX   PubMed=8051082; DOI=10.1016/s0021-9258(17)32117-8;
RA   Schroeder W.T., Stewart-Galetka S., Mandavilli S., Parry D.A.,
RA   Goldsmith L., Duvic M.;
RT   "Cloning and characterization of a novel epidermal cell surface antigen
RT   (ESA).";
RL   J. Biol. Chem. 269:19983-19991(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 20-428.
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 50-428.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH ECPAS.
RX   PubMed=20682791; DOI=10.1074/jbc.m110.154120;
RA   Gorbea C., Pratt G., Ustrell V., Bell R., Sahasrabudhe S., Hughes R.E.,
RA   Rechsteiner M.;
RT   "A protein interaction network for Ecm29 links the 26 S proteasome to
RT   molecular motors and endosomal components.";
RL   J. Biol. Chem. 285:31616-31633(2010).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   PALMITOYLATION AT CYS-4; CYS-19 AND CYS-20, AND MUTAGENESIS OF CYS-4;
RP   CYS-19 AND CYS-20.
RX   PubMed=22081607; DOI=10.1074/jbc.m111.306183;
RA   Li Y., Martin B.R., Cravatt B.F., Hofmann S.L.;
RT   "DHHC5 protein palmitoylates flotillin-2 and is rapidly degraded on
RT   induction of neuronal differentiation in cultured cells.";
RL   J. Biol. Chem. 287:523-530(2012).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-405, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   MYRISTOYLATION AT GLY-2, CLEAVAGE OF INITIATOR METHIONINE, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=25255805; DOI=10.1038/ncomms5919;
RA   Thinon E., Serwa R.A., Broncel M., Brannigan J.A., Brassat U., Wright M.H.,
RA   Heal W.P., Wilkinson A.J., Mann D.J., Tate E.W.;
RT   "Global profiling of co- and post-translationally N-myristoylated proteomes
RT   in human cells.";
RL   Nat. Commun. 5:4919-4919(2014).
CC   -!- FUNCTION: May act as a scaffolding protein within caveolar membranes,
CC       functionally participating in formation of caveolae or caveolae-like
CC       vesicles. May be involved in epidermal cell adhesion and epidermal
CC       structure and function.
CC   -!- SUBUNIT: Heterooligomeric complex of flotillin-1 and flotillin-2 and
CC       caveolin-1 and caveolin-2 (By similarity). Interacts with ECPAS.
CC       {ECO:0000250, ECO:0000269|PubMed:20682791}.
CC   -!- INTERACTION:
CC       Q14254; O75955: FLOT1; NbExp=6; IntAct=EBI-348613, EBI-603643;
CC       Q14254; Q6FHG5: SNCG; NbExp=2; IntAct=EBI-348613, EBI-9776333;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:20682791};
CC       Peripheral membrane protein {ECO:0000269|PubMed:20682791}. Membrane,
CC       caveola {ECO:0000269|PubMed:20682791}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:20682791}. Endosome {ECO:0000269|PubMed:20682791}.
CC       Membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}. Note=Membrane-
CC       associated protein of caveolae.
CC   -!- TISSUE SPECIFICITY: In skin, expressed in epidermis and epidermal
CC       appendages but not in dermis. Expressed in all layers of the epidermis
CC       except the basal layer. In hair follicles, expressed in the suprabasal
CC       layer but not the basal layer. Also expressed in melanoma and carcinoma
CC       cell lines, fibroblasts and foreskin melanocytes.
CC   -!- PTM: ZDHHC5-catalyzed palmitoylation predominantly occurs at Cys-4.
CC       ZDHHC5-catalyzed palmitoylation may be required for the formation of
CC       higher-order complexes and for neurite outgrowth in cultured neural
CC       stem cells. {ECO:0000269|PubMed:22081607}.
CC   -!- SIMILARITY: Belongs to the band 7/mec-2 family. Flotillin subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA65729.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC024267; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M60922; AAA65729.1; ALT_INIT; mRNA.
DR   EMBL; BC017292; AAH17292.2; -; mRNA.
DR   EMBL; BT019478; AAV38285.1; -; mRNA.
DR   CCDS; CCDS11245.2; -.
DR   PIR; A53664; A53664.
DR   RefSeq; NP_004466.2; NM_004475.2.
DR   RefSeq; XP_016879883.1; XM_017024394.1.
DR   RefSeq; XP_016879884.1; XM_017024395.1.
DR   AlphaFoldDB; Q14254; -.
DR   BMRB; Q14254; -.
DR   BioGRID; 108608; 298.
DR   CORUM; Q14254; -.
DR   IntAct; Q14254; 117.
DR   MINT; Q14254; -.
DR   STRING; 9606.ENSP00000378368; -.
DR   iPTMnet; Q14254; -.
DR   PhosphoSitePlus; Q14254; -.
DR   SwissPalm; Q14254; -.
DR   BioMuta; FLOT2; -.
DR   DMDM; 254763294; -.
DR   EPD; Q14254; -.
DR   jPOST; Q14254; -.
DR   MassIVE; Q14254; -.
DR   MaxQB; Q14254; -.
DR   PaxDb; Q14254; -.
DR   PeptideAtlas; Q14254; -.
DR   PRIDE; Q14254; -.
DR   ProteomicsDB; 59951; -.
DR   Antibodypedia; 666; 333 antibodies from 39 providers.
DR   DNASU; 2319; -.
DR   Ensembl; ENST00000394908.9; ENSP00000378368.3; ENSG00000132589.16.
DR   GeneID; 2319; -.
DR   KEGG; hsa:2319; -.
DR   MANE-Select; ENST00000394908.9; ENSP00000378368.3; NM_004475.3; NP_004466.2.
DR   UCSC; uc002hdc.4; human.
DR   CTD; 2319; -.
DR   DisGeNET; 2319; -.
DR   GeneCards; FLOT2; -.
DR   HGNC; HGNC:3758; FLOT2.
DR   HPA; ENSG00000132589; Low tissue specificity.
DR   MIM; 131560; gene.
DR   neXtProt; NX_Q14254; -.
DR   OpenTargets; ENSG00000132589; -.
DR   PharmGKB; PA28176; -.
DR   VEuPathDB; HostDB:ENSG00000132589; -.
DR   eggNOG; KOG2668; Eukaryota.
DR   GeneTree; ENSGT00560000077232; -.
DR   HOGENOM; CLU_038134_1_0_1; -.
DR   InParanoid; Q14254; -.
DR   OMA; MWRVAEP; -.
DR   OrthoDB; 812555at2759; -.
DR   PhylomeDB; Q14254; -.
DR   TreeFam; TF324879; -.
DR   PathwayCommons; Q14254; -.
DR   Reactome; R-HSA-5213460; RIPK1-mediated regulated necrosis.
DR   Reactome; R-HSA-5675482; Regulation of necroptotic cell death.
DR   Reactome; R-HSA-8849932; Synaptic adhesion-like molecules.
DR   Reactome; R-HSA-8980692; RHOA GTPase cycle.
DR   Reactome; R-HSA-9013026; RHOB GTPase cycle.
DR   Reactome; R-HSA-9013106; RHOC GTPase cycle.
DR   Reactome; R-HSA-9696264; RND3 GTPase cycle.
DR   Reactome; R-HSA-9696273; RND1 GTPase cycle.
DR   SignaLink; Q14254; -.
DR   BioGRID-ORCS; 2319; 10 hits in 1073 CRISPR screens.
DR   ChiTaRS; FLOT2; human.
DR   GeneWiki; FLOT2; -.
DR   GenomeRNAi; 2319; -.
DR   Pharos; Q14254; Tbio.
DR   PRO; PR:Q14254; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q14254; protein.
DR   Bgee; ENSG00000132589; Expressed in granulocyte and 194 other tissues.
DR   ExpressionAtlas; Q14254; baseline and differential.
DR   Genevisible; Q14254; HS.
DR   GO; GO:0002080; C:acrosomal membrane; IEA:Ensembl.
DR   GO; GO:0005912; C:adherens junction; IDA:UniProtKB.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005901; C:caveola; IDA:MGI.
DR   GO; GO:0044291; C:cell-cell contact zone; IDA:UniProtKB.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:UniProtKB.
DR   GO; GO:0032839; C:dendrite cytoplasm; IEA:GOC.
DR   GO; GO:0030139; C:endocytic vesicle; IDA:UniProtKB.
DR   GO; GO:0005768; C:endosome; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016600; C:flotillin complex; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0030027; C:lamellipodium; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0001931; C:uropod; IDA:UniProtKB.
DR   GO; GO:0031982; C:vesicle; IDA:UniProtKB.
DR   GO; GO:0098937; P:anterograde dendritic transport; IEA:Ensembl.
DR   GO; GO:0007155; P:cell adhesion; NAS:ProtInc.
DR   GO; GO:0008544; P:epidermis development; TAS:ProtInc.
DR   GO; GO:1902992; P:negative regulation of amyloid precursor protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:1903905; P:positive regulation of establishment of T cell polarity; IMP:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:ARUK-UCL.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IMP:UniProtKB.
DR   GO; GO:0044860; P:protein localization to plasma membrane raft; IMP:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; IMP:UniProtKB.
DR   GO; GO:0045661; P:regulation of myoblast differentiation; IEP:UniProtKB.
DR   GO; GO:0099072; P:regulation of postsynaptic membrane neurotransmitter receptor levels; IEA:Ensembl.
DR   Gene3D; 3.30.479.30; -; 1.
DR   InterPro; IPR001107; Band_7.
DR   InterPro; IPR036013; Band_7/SPFH_dom_sf.
DR   InterPro; IPR027705; Flotillin_fam.
DR   PANTHER; PTHR13806; PTHR13806; 1.
DR   Pfam; PF01145; Band_7; 1.
DR   SMART; SM00244; PHB; 1.
DR   SUPFAM; SSF117892; SSF117892; 1.
PE   1: Evidence at protein level;
KW   Cell adhesion; Cell membrane; Endosome; Lipoprotein; Membrane; Myristate;
KW   Palmitate; Phosphoprotein; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:25255805"
FT   CHAIN           2..428
FT                   /note="Flotillin-2"
FT                   /id="PRO_0000094049"
FT   MOD_RES         405
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000269|PubMed:25255805"
FT   LIPID           4
FT                   /note="S-palmitoyl cysteine; by ZDHHC5"
FT                   /evidence="ECO:0000269|PubMed:22081607"
FT   LIPID           19
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:22081607"
FT   LIPID           20
FT                   /note="S-palmitoyl cysteine; by ZDHHC5"
FT                   /evidence="ECO:0000269|PubMed:22081607"
FT   VARIANT         328
FT                   /note="A -> T (in dbSNP:rs3736238)"
FT                   /id="VAR_024375"
FT   MUTAGEN         4
FT                   /note="C->S: Loss of ZDHHC5-catalyzed palmitoylation; when
FT                   associated with S-20. Partial loss of ZDHHC5-catalyzed
FT                   palmitoylation; when associated with S-19. Complete loss of
FT                   palmitoylation; when associated with S-19 and S-20."
FT                   /evidence="ECO:0000269|PubMed:22081607"
FT   MUTAGEN         19
FT                   /note="C->S: Partial loss of ZDHHC5-catalyzed
FT                   palmitoylation; when associated with S-4 or S-20. Complete
FT                   loss of palmitoylation; when associated with S-4 and S-20."
FT                   /evidence="ECO:0000269|PubMed:22081607"
FT   MUTAGEN         20
FT                   /note="C->S: Loss of ZDHHC5-catalyzed palmitoylation; when
FT                   associated with S-4. Partial loss of ZDHHC5-catalyzed
FT                   palmitoylation; when associated with S-19. Complete loss of
FT                   palmitoylation; when associated with S-4 and S-19."
FT                   /evidence="ECO:0000269|PubMed:22081607"
FT   CONFLICT        8
FT                   /note="G -> R (in Ref. 1; AC024267 and 2; AAA65729)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   428 AA;  47064 MW;  F690BFE0151D3BD7 CRC64;
     MGNCHTVGPN EALVVSGGCC GSDYKQYVFG GWAWAWWCIS DTQRISLEIM TLQPRCEDVE
     TAEGVALTVT GVAQVKIMTE KELLAVACEQ FLGKNVQDIK NVVLQTLEGH LRSILGTLTV
     EQIYQDRDQF AKLVREVAAP DVGRMGIEIL SFTIKDVYDK VDYLSSLGKT QTAVVQRDAD
     IGVAEAERDA GIREAECKKE MLDVKFMADT KIADSKRAFE LQKSAFSEEV NIKTAEAQLA
     YELQGAREQQ KIRQEEIEIE VVQRKKQIAV EAQEILRTDK ELIATVRRPA EAEAHRIQQI
     AEGEKVKQVL LAQAEAEKIR KIGEAEAAVI EAMGKAEAER MKLKAEAYQK YGDAAKMALV
     LEALPQIAAK IAAPLTKVDE IVVLSGDNSK VTSEVNRLLA ELPASVHALT GVDLSKIPLI
     KKATGVQV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024